Advanced Oncotherapy.
178 announcements.
178 announcements.
Time | Date | Ticker | Company | Announcement |
---|---|---|---|---|
07:00 | 03-08-2022 | AVO | Advanced Oncotherapy | Equity Subscription and Issue of Warrants |
16:30 | 29-07-2022 | AVO | Advanced Oncotherapy | Result of AGM |
12:30 | 07-07-2022 | AVO | Advanced Oncotherapy | Holding(s) in Company |
17:00 | 30-06-2022 | AVO | Advanced Oncotherapy | Total Voting Rights |
09:00 | 30-06-2022 | AVO | Advanced Oncotherapy | Final results for the year ended 31 December 2021 |
07:00 | 28-06-2022 | AVO | Advanced Oncotherapy | Equity Subscription and Issue of Warrants |
07:00 | 13-06-2022 | AVO | Advanced Oncotherapy | Equity Subscription and Issue of Warrants |
17:00 | 31-05-2022 | AVO | Advanced Oncotherapy | Total Voting Rights |
12:17 | 27-05-2022 | AVO | Advanced Oncotherapy | Holding(s) in Company |
07:00 | 11-05-2022 | AVO | Advanced Oncotherapy | LIGHT system potential in delivering FLASH |
17:00 | 29-04-2022 | AVO | Advanced Oncotherapy | Total Voting Rights |
07:00 | 27-04-2022 | AVO | Advanced Oncotherapy | Video showcases progress on LIGHT system process |
07:00 | 26-04-2022 | AVO | Advanced Oncotherapy | Operational update |
07:00 | 22-04-2022 | AVO | Advanced Oncotherapy | Update re admission of Subscription Shares |
16:05 | 19-04-2022 | AVO | Advanced Oncotherapy | Update re admission of Subscription Shares |
07:13 | 12-04-2022 | AVO | Advanced Oncotherapy | Equity Subscription and Issue of Warrants |
17:00 | 31-03-2022 | AVO | Advanced Oncotherapy | Total Voting Rights |
09:30 | 25-03-2022 | AVO | Advanced Oncotherapy | £2m Subscription, Add'l Loan and Issue of Warrants |
07:15 | 14-03-2022 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO) - LIGHT: regulatory update |
09:00 | 04-03-2022 | AVO | Advanced Oncotherapy | Director/PDMR Notification |
17:05 | 03-03-2022 | AVO | Advanced Oncotherapy | Director/PDMR Notification |
16:10 | 02-03-2022 | AVO | Advanced Oncotherapy | Director/PDMR Notification |
07:00 | 01-03-2022 | AVO | Advanced Oncotherapy | Operational update |
17:00 | 28-02-2022 | AVO | Advanced Oncotherapy | Total Voting Rights |
16:25 | 17-02-2022 | AVO | Advanced Oncotherapy | Exercise of Warrants and Issue of Equity |
17:00 | 31-01-2022 | AVO | Advanced Oncotherapy | Total Voting Rights |
15:17 | 13-01-2022 | AVO | Advanced Oncotherapy | Exercise of Warrants and Issue of Equity |
13:00 | 31-12-2021 | AVO | Advanced Oncotherapy | Total Voting Rights |
07:00 | 13-12-2021 | AVO | Advanced Oncotherapy | Technical update on delivery of first LIGHT system |
07:00 | 10-12-2021 | AVO | Advanced Oncotherapy | Holding(s) in Company |
17:09 | 03-12-2021 | AVO | Advanced Oncotherapy | Holding(s) in Company |
13:29 | 02-12-2021 | AVO | Advanced Oncotherapy | Issue of warrants and equity and Loan Extension |
17:00 | 30-11-2021 | AVO | Advanced Oncotherapy | Total Voting Rights |
08:30 | 15-11-2021 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): On the home straight |
11:23 | 10-11-2021 | AVO | Advanced Oncotherapy | Holding(s) in Company |
14:28 | 08-11-2021 | AVO | Advanced Oncotherapy | Exercise of Warrants and Issue of Equity |
13:44 | 04-11-2021 | AVO | Advanced Oncotherapy | Holding(s) in Company |
07:00 | 27-10-2021 | AVO | Advanced Oncotherapy | Presentation highlights LIGHT system superiority |
17:00 | 30-09-2021 | AVO | Advanced Oncotherapy | Total Voting Rights |
07:00 | 30-09-2021 | AVO | Advanced Oncotherapy | Interim Results |
11:27 | 23-09-2021 | AVO | Advanced Oncotherapy | Exercise of Warrants and Issue of Equity |
07:00 | 20-09-2021 | AVO | Advanced Oncotherapy | Update re admission of Subscription Shares |
07:00 | 03-09-2021 | AVO | Advanced Oncotherapy | Update on admission of Subscription Shares |
16:48 | 16-08-2021 | AVO | Advanced Oncotherapy | Exercise of Warrants and Issue of Equity |
13:50 | 12-08-2021 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO) Funded to completion |
07:00 | 11-08-2021 | AVO | Advanced Oncotherapy | Proposed subscription and issuance of shares |
15:37 | 02-08-2021 | AVO | Advanced Oncotherapy | Result of AGM |
16:58 | 30-07-2021 | AVO | Advanced Oncotherapy | Result of AGM |
14:19 | 13-07-2021 | AVO | Advanced Oncotherapy | Holdings in company |
07:00 | 30-06-2021 | AVO | Advanced Oncotherapy | Final Results for the year ended 31 December 2020 |
07:00 | 03-06-2021 | AVO | Advanced Oncotherapy | Saba Partners sign LOI for LIGHT system |
17:00 | 28-05-2021 | AVO | Advanced Oncotherapy PLC | Total Voting Rights |
10:37 | 26-05-2021 | AVO | Advanced Oncotherapy PLC | Exercise of Warrants and Issue of Equity |
17:38 | 28-04-2021 | AVO | Advanced Oncotherapy PLC | Exercise of Warrants and Issue of Equity |
17:00 | 31-03-2021 | AVO | Advanced Oncotherapy PLC | Total Voting Rights |
07:00 | 12-03-2021 | AVO | Advanced Oncotherapy PLC | Study shows the potential superiority of LIGHT |
07:00 | 11-03-2021 | AVO | Advanced Oncotherapy PLC | Exercise of Warrants and Issue of Equity |
17:00 | 26-02-2021 | AVO | Advanced Oncotherapy PLC | Total Voting Rights |
10:39 | 17-02-2021 | AVO | Advanced Oncotherapy PLC | Exercise of Warrants and Issue of Equity |
07:00 | 22-01-2021 | AVO | Advanced Oncotherapy PLC | Equity fundraise of c.5.9m |
07:00 | 13-01-2021 | AVO | Advanced Oncotherapy PLC | Exercise of Warrants and Issue of Equity |
07:00 | 11-01-2021 | AVO | Advanced Oncotherapy PLC | Technical update |
11:05 | 06-01-2021 | AVO | Advanced Oncotherapy PLC | Second Price Monitoring Extn |
11:00 | 06-01-2021 | AVO | Advanced Oncotherapy PLC | Price Monitoring Extension |
07:00 | 06-01-2021 | AVO | Advanced Oncotherapy PLC | Financing partnership agreement with DiaMedCare AG |
14:42 | 23-11-2020 | AVO | Advanced Oncotherapy PLC | Holding(s) in Company |
14:02 | 17-11-2020 | AVO | Advanced Oncotherapy PLC | Holding(s) in Company |
07:00 | 10-11-2020 | AVO | Advanced Oncotherapy PLC | Holding(s) in Company |
17:00 | 30-10-2020 | AVO | Advanced Oncotherapy PLC | Total Voting Rights |
07:00 | 26-10-2020 | AVO | Advanced Oncotherapy PLC | Equity fundraise of c.7.7m |
07:00 | 19-10-2020 | AVO | Advanced Oncotherapy PLC | Investor Day Update |
14:06 | 08-10-2020 | AVO | Advanced Oncotherapy PLC | Second Price Monitoring Extn |
14:00 | 08-10-2020 | AVO | Advanced Oncotherapy PLC | Price Monitoring Extension |
07:00 | 06-10-2020 | AVO | Advanced Oncotherapy PLC | Replacement: Grant of LTIP Options |
07:01 | 05-10-2020 | AVO | Advanced Oncotherapy PLC | Notice of Investor Day |
07:00 | 05-10-2020 | AVO | Advanced Oncotherapy PLC | Grant of LTIP Options |
07:00 | 29-09-2020 | AVO | Advanced Oncotherapy | Interim Results |
07:00 | 29-09-2020 | AVO | Advanced Oncotherapy | Directorate Appointment |
07:00 | 08-09-2020 | AVO | Advanced Oncotherapy | Technical Development Update |
07:00 | 07-09-2020 | AVO | Advanced Oncotherapy | Appointment of Joint Broker |
07:00 | 21-08-2020 | AVO | Advanced Oncotherapy | Draw down from Nerano Pharma debt facility |
16:30 | 18-08-2020 | AVO | Advanced Oncotherapy | Director/PDMR Shareholding |
14:52 | 29-07-2020 | AVO | Advanced Oncotherapy | Result of AGM and Directorate Changes |
07:15 | 02-07-2020 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): End-goal fast approaching |
07:01 | 29-06-2020 | AVO | Advanced Oncotherapy | Final Results for the year ended 31 December 2019 |
07:00 | 29-06-2020 | AVO | Advanced Oncotherapy | Strategic funding partnership and debt facility |
07:00 | 17-06-2020 | AVO | Advanced Oncotherapy | Holding(s) in Company |
07:00 | 08-06-2020 | AVO | Advanced Oncotherapy | Directorate Changes and Notice of Results |
17:30 | 03-06-2020 | AVO | Advanced Oncotherapy | Holding(s) in Company |
17:00 | 29-05-2020 | AVO | Advanced Oncotherapy | Total Voting Rights |
16:30 | 20-05-2020 | AVO | Advanced Oncotherapy | Holding(s) in Company |
07:00 | 21-04-2020 | AVO | Advanced Oncotherapy | Notice of GM and Posting of Circular |
07:30 | 09-04-2020 | AVO | Advanced Oncotherapy | Further re Subscription and Issue of Equity |
07:00 | 09-04-2020 | AVO | Advanced Oncotherapy | Proposed Subscription to raise c.£15 million |
15:40 | 26-02-2020 | AVO | Hardman & Co Research | Q&A with Dr Martin Hall on Advanced Oncotherapy (AVO): Confidence in LIGHT gaining momentum |
07:00 | 20-02-2020 | AVO | Advanced Oncotherapy | UHB and AVO to collaborate over LIGHT system |
11:45 | 17-02-2020 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Confidence in LIGHT gaining momentum |
07:00 | 17-02-2020 | AVO | Advanced Oncotherapy | Purchase of a LIGHT proton therapy system |
07:00 | 11-02-2020 | AVO | Advanced Oncotherapy | Partnership with The London Clinic |
07:15 | 04-12-2019 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Proving the accuracy and superiority of minibeams |
07:00 | 04-12-2019 | AVO | Advanced Oncotherapy | Two-Year Collaborative Research Study |
17:45 | 03-12-2019 | AVO | Advanced Oncotherapy | Holding(s) in Company |
17:00 | 29-11-2019 | AVO | Advanced Oncotherapy | Total Voting Rights |
10:15 | 28-11-2019 | AVO | Advanced Oncotherapy | Holding(s) in Company |
07:00 | 20-11-2019 | AVO | Advanced Oncotherapy | Subscription to raise c.GBP 2.7 million |
09:11 | 11-11-2019 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): FLASH benefits from new US reimbursement |
15:35 | 06-11-2019 | AVO | Advanced Oncotherapy | Total Voting Rights |
07:00 | 10-10-2019 | AVO | Advanced Oncotherapy | Change of Broker |
17:15 | 30-09-2019 | AVO | Advanced Oncotherapy | Total Voting Rights |
07:00 | 30-09-2019 | AVO | Advanced Oncotherapy | Further re funding for first LIGHT system |
07:00 | 30-09-2019 | AVO | Advanced Oncotherapy | Half-year Report |
16:48 | 09-09-2019 | AVO | Advanced Oncotherapy | Exercise of Warrants and Issue of Equity |
17:00 | 30-08-2019 | AVO | Advanced Oncotherapy | Total Voting Rights |
14:06 | 29-08-2019 | AVO | Advanced Oncotherapy | Holding(s) in Company |
07:00 | 27-08-2019 | AVO | Advanced Oncotherapy | Total Voting Rights and Directors' Shareholdings |
10:45 | 08-08-2019 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Nearing the end-goal |
07:00 | 07-08-2019 | AVO | Advanced Oncotherapy | Issue of equity and new debt facility |
11:00 | 06-08-2019 | AVO | Advanced Oncotherapy | Price Monitoring Extension |
11:05 | 06-08-2019 | AVO | Advanced Oncotherapy | Second Price Monitoring Extn |
17:12 | 25-07-2019 | AVO | Advanced Oncotherapy | Result of AGM |
07:00 | 25-07-2019 | AVO | Advanced Oncotherapy | AGM Statement & Technological update |
07:00 | 22-07-2019 | AVO | Advanced Oncotherapy | Harley Street update |
07:00 | 28-06-2019 | AVO | Advanced Oncotherapy | Final Results |
07:00 | 03-06-2019 | AVO | Advanced Oncotherapy | Technological update |
17:30 | 31-05-2019 | AVO | Advanced Oncotherapy | Total Voting Rights |
17:29 | 17-05-2019 | AVO | Advanced Oncotherapy | Holding(s) in Company |
12:20 | 13-05-2019 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Commercialising a breakthrough technology |
07:00 | 10-05-2019 | AVO | Advanced Oncotherapy | Debt facility secured |
10:26 | 16-04-2019 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Preparing for commercialisation |
07:00 | 16-04-2019 | AVO | Advanced Oncotherapy | Senior Management Appointment |
09:00 | 07-03-2019 | AVO | Advanced Oncotherapy | Price Monitoring Extension |
07:00 | 22-02-2019 | AVO | Advanced Oncotherapy | Grant of options |
07:00 | 01-02-2019 | AVO | Advanced Oncotherapy | Appointment of Nominated Adviser and Joint Broker |
11:45 | 30-01-2019 | AVO | Advanced Oncotherapy | Schedule 2(g) Disclosure |
09:38 | 29-01-2019 | AVO | Advanced Oncotherapy | Total Voting Rights and Significant Shareholdings |
12:14 | 24-01-2019 | AVO | Advanced Oncotherapy | Schedule 2(g) Disclosure |
15:29 | 22-01-2019 | AVO | Advanced Oncotherapy | Result of General Meeting |
11:15 | 21-01-2019 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Important regulatory milestone: ISO approval |
07:00 | 21-01-2019 | AVO | Advanced Oncotherapy | ISO 13485:2016 certification for medical devices |
10:15 | 21-12-2018 | AVO | Advanced Oncotherapy | Launch of 2018 SAYE Scheme |
07:00 | 21-12-2018 | AVO | Advanced Oncotherapy | Proposed Direct Subscription to raise £10.0m |
16:30 | 16-10-2018 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Four components int... |
15:58 | 16-10-2018 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Treatment planning ... |
07:30 | 10-10-2018 | AVO | Advanced Oncotherapy | GPSL Research - Flash Note on AVO |
07:00 | 10-10-2018 | AVO | Advanced Oncotherapy | Technological update |
11:07 | 04-10-2018 | AVO | Advanced Oncotherapy | GPSL Research - Flash Note on AVO |
07:00 | 28-09-2018 | AVO | Advanced Oncotherapy | Half-year Report |
07:00 | 27-09-2018 | AVO | Advanced Oncotherapy | Technological update |
11:32 | 10-09-2018 | AVO | Advanced Oncotherapy | Holding(s) in Company |
11:52 | 07-09-2018 | AVO | Advanced Oncotherapy | Holding(s) in Company |
17:15 | 03-09-2018 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Treatment planning ... |
11:38 | 03-09-2018 | AVO | Advanced Oncotherapy | Completion of the £6.41m Placing |
09:57 | 29-08-2018 | AVO | Hardman & Co Research | Advanced Oncotherapy (AVO): Treatment planning ... |
07:00 | 28-08-2018 | AVO | Advanced Oncotherapy | Director Declaration |
07:00 | 09-08-2018 | AVO | Advanced Oncotherapy | Exercise of Warrants and Issue of Shares |
07:00 | 02-08-2018 | AVO | Advanced Oncotherapy | £6.41m Placing |
15:34 | 25-07-2018 | AVO | Advanced Oncotherapy | Result of AGM |
16:40 | 04-07-2018 | AVO | Advanced Oncotherapy | Second Price Monitoring Extn |
16:35 | 04-07-2018 | AVO | Advanced Oncotherapy | Price Monitoring Extension |
11:05 | 04-07-2018 | AVO | Advanced Oncotherapy | Second Price Monitoring Extn |
11:00 | 04-07-2018 | AVO | Advanced Oncotherapy | Price Monitoring Extension |
09:05 | 04-07-2018 | AVO | Advanced Oncotherapy | Second Price Monitoring Extn |
09:00 | 04-07-2018 | AVO | Advanced Oncotherapy | Price Monitoring Extension |
07:00 | 02-07-2018 | AVO | Advanced Oncotherapy | Directorate Changes |
07:00 | 27-06-2018 | AVO | Advanced Oncotherapy | Final Results |
07:00 | 31-05-2018 | AVO | Advanced Oncotherapy | Update on financing |
07:00 | 29-05-2018 | AVO | Advanced Oncotherapy | Technological update |
07:00 | 12-01-2018 | AVO | Advanced Oncotherapy | Director dealing |
11:48 | 23-01-2018 | AVO | Advanced Oncotherapy | Result of Meeting |
07:00 | 16-02-2018 | AVO | Advanced Oncotherapy | Completion of the Subscription Agreement |
16:05 | 23-02-2018 | AVO | Advanced Oncotherapy | Holding(s) in Company |
07:15 | 12-03-2018 | AVO | Advanced Oncotherapy | Hardman & Co Research: Confidence greatly boosted |
09:43 | 03-04-2018 | AVO | Advanced Oncotherapy | Update on Distribution Agreement |
07:00 | 05-04-2018 | AVO | Advanced Oncotherapy | Holding(s) in Company |
13:50 | 26-04-2018 | AVO | Advanced Oncotherapy | GPSL Research on Advanced Oncotherapy Plc |
07:00 | 08-05-2018 | AVO | Advanced Oncotherapy | UK assembly and testing site agreement |
07:00 | 11-05-2018 | AVO | Advanced Oncotherapy | Update on Distribution Agreement Payment |
16:35 | 11-05-2018 | AVO | Advanced Oncotherapy | Price Monitoring Extension |